C. Wei

458 total citations
8 papers, 305 citations indexed

About

C. Wei is a scholar working on Oncology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, C. Wei has authored 8 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Complementary and alternative medicine. Recurrent topics in C. Wei's work include Nitric Oxide and Endothelin Effects (2 papers), Cardiovascular and exercise physiology (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). C. Wei is often cited by papers focused on Nitric Oxide and Endothelin Effects (2 papers), Cardiovascular and exercise physiology (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). C. Wei collaborates with scholars based in United States, United Kingdom and Singapore. C. Wei's co-authors include Gregory D. Ayers, Jacob A. Berry, Balraj Singh, Angela Shoher, Anthony Lucci, Daniel Tuvin, Dina Lev, Peter W. T. Pisters, D.A. Anaya and Alexander J. Lazar and has published in prestigious journals such as Oncogene, Free Radical Biology and Medicine and Annals of Oncology.

In The Last Decade

C. Wei

8 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Wei United States 5 135 128 83 53 49 8 305
Patrick Julier United Kingdom 6 158 1.2× 70 0.5× 42 0.5× 29 0.5× 87 1.8× 9 296
Feifeng Ren China 11 42 0.3× 66 0.5× 130 1.6× 46 0.9× 26 0.5× 24 363
Silin Lv China 11 69 0.5× 76 0.6× 209 2.5× 61 1.2× 13 0.3× 20 404
Chiharu Doi Japan 13 111 0.8× 100 0.8× 288 3.5× 24 0.5× 32 0.7× 20 571
Juhyung Woo United States 11 87 0.6× 99 0.8× 270 3.3× 31 0.6× 23 0.5× 26 507
Nobuto Okamoto Japan 12 71 0.5× 39 0.3× 121 1.5× 26 0.5× 25 0.5× 23 342
Ettickan Boopathi United States 15 97 0.7× 68 0.5× 205 2.5× 17 0.3× 7 0.1× 27 463
Lun Tan China 12 40 0.3× 68 0.5× 205 2.5× 84 1.6× 21 0.4× 26 426
Ling Yan China 11 125 0.9× 59 0.5× 104 1.3× 13 0.2× 56 1.1× 18 353
Kenneth Shewmake United States 6 64 0.5× 159 1.2× 114 1.4× 19 0.4× 205 4.2× 9 579

Countries citing papers authored by C. Wei

Since Specialization
Citations

This map shows the geographic impact of C. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wei more than expected).

Fields of papers citing papers by C. Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wei. The network helps show where C. Wei may publish in the future.

Co-authorship network of co-authors of C. Wei

This figure shows the co-authorship network connecting the top 25 collaborators of C. Wei. A scholar is included among the top collaborators of C. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Wei. C. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
3.
Rodón, Jordi, Daniel Shao-Weng Tan, Ignacio Garrido‐Laguna, et al.. (2023). Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial. ESMO Open. 8(4). 101584–101584. 8 indexed citations
4.
Sangai, Takafumi, et al.. (2017). Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer. Oncogenesis. 6(10). e385–e385. 52 indexed citations
5.
Guo, Ming, et al.. (2012). P1.11 Stage-Associated Difference in Microrna Expression in Lung Adenocarcinoma from Smokers and Non-Smokers. Annals of Oncology. 23. v15–v15. 1 indexed citations
6.
Euscher, Elizabeth D., et al.. (2011). Reverse-phase protein lysate array identified potential therapeutic targets in uterine carcinosarcoma. Gynecologic Oncology. 120. S92–S92. 1 indexed citations
7.
Lahat, Guy, Daniel Tuvin, C. Wei, et al.. (2008). New Perspectives for Staging and Prognosis in Soft Tissue Sarcoma. Annals of Surgical Oncology. 15(10). 2739–2748. 110 indexed citations
8.
Singh, Balraj, Jacob A. Berry, Angela Shoher, et al.. (2007). COX-2 involvement in breast cancer metastasis to bone. Oncogene. 26(26). 3789–3796. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026